NewsRx

Search our medical news database

40 Days for Life

New Chicago Ordinance Targets 40 Days for Life, Tramples Pro-Life Americans' Free Speech Rights

Published in Health Business Week, October 23rd, 2009

"You know a law is an improper intrusion on First Amendment rights when even the American Civil Liberties Union sides with pro-life interests in opposing certain aspects of a legislative action," said David Bereit, national director of 40 Days for Life. "Such is the case with the new bubble zone ordinance, approved Wednesday by Chicago's city council, which unconstitutionally restricts the peaceful activities of pro-life individuals on the sidewalk in front of abortion facilities in an attempt to cripple the ongoing 40 Days for Life prayer vigils."

The new city ordinance could not only block sidewalk counseling and the display of pro-life signs within 50 feet of all...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Health Business Week


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook